Header Logo

David F. Driscoll PhD

TitleAssociate Professor
InstitutionUMass Chan Medical School
DepartmentMedicine
AddressSS LLC
19 Norfolk Avenue
Easton MA 02334
vCardDownload vCard
    Other Positions
    InstitutionT.H. Chan School of Medicine
    DepartmentMedicine
    DivisionGastroenterology


    Collapse Biography 
    Collapse education and training
    Massachusetts College of Pharmacy and Health Sciences, Boston, MA, United StatesBSPharmacy
    Massachusetts College of Pharmacy and Health Sciences, Boston, MA, United StatesMSPharmaceutics
    Massachusetts College of Pharmacy and Health Sciences, Boston, MA, United StatesPHDPharmaceutics

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Driscoll DF. Lipid nanoparticle-based COVID-19 vaccines: Concerns about stability. Am J Health Syst Pharm. 2022 Jun 14. PMID: 35700953.
      Citations:    Fields:    
    2. Welty F, Bistrian B, Driscoll D. Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk. JAMA. 2021 04 06; 325(13):1333. PMID: 33821903.
      Citations:    Fields:    Translation:Humans
    3. Driscoll DF. Potentially Important Therapeutic Interactions between Antibiotics, and a Specially Engineered Emulsion Drug Vehicle Containing Krill-Oil-Based Phospholipids and Omega-3 Fatty Acids. Antibiotics (Basel). 2018 Mar 10; 7(1). PMID: 29534425.
      Citations:    
    4. Driscoll DF. Regarding "A Comparison of Fish Oil Sources for Parenteral Lipid Emulsions in a Murine Model". JPEN J Parenter Enteral Nutr. 2017 07; 41(5):703. PMID: 28754085.
      Citations:    Fields:    Translation:Animals
    5. Bonaterra GA, Driscoll D, Schwarzbach H, Kinscherf R. Krill Oil-In-Water Emulsion Protects against Lipopolysaccharide-Induced Proinflammatory Activation of Macrophages In Vitro. Mar Drugs. 2017 Mar 15; 15(3). PMID: 28294970.
      Citations: 6     Fields:    Translation:HumansCells
    6. Driscoll DF. Pharmaceutical and Clinical Aspects of Lipid Injectable Emulsions. JPEN J Parenter Enteral Nutr. 2017 01; 41(1):125-134. PMID: 27738263.
      Citations: 3     Fields:    Translation:Humans
    7. Gramlich L, Meddings L, Alberda C, Wichansawakun S, Robbins S, Driscoll D, Bistrian B. Essential Fatty Acid Deficiency in 2015: The Impact of Novel Intravenous Lipid Emulsions. JPEN J Parenter Enteral Nutr. 2015 Sep; 39(1 Suppl):61S-6S. PMID: 26187936.
      Citations: 9     Fields:    Translation:Humans
    8. Driscoll DF. Commercial lipid emulsions and all-in-one mixtures for intravenous infusion - composition and physicochemical properties. World Rev Nutr Diet. 2015; 112:48-56. PMID: 25471801.
      Citations: 2     Fields:    Translation:Humans
    9. Bonaterra GA, Wakenhut F, Röthlein D, Wolf M, Bistrian BR, Driscoll D, Kinscherf R. Cytoprotection by omega-3 fatty acids as a therapeutic drug vehicle when combined with nephrotoxic drugs in an intravenous emulsion: Effects on intraglomerular mesangial cells. Toxicol Rep. 2014; 1:843-857. PMID: 28962296.
      Citations:    
    10. Driscoll DF. Assessment of the physicochemical stability of all-in-one parenteral emulsions for neonates according to USP specifications, Athanasiou et al. JPEN J Parenter Enteral Nutr. 2014 Sep; 38(7):775-7. PMID: 24898212.
      Citations: 1     Fields:    Translation:Humans
    11. Vanek VW, Allen P, Harvey Banchik LP, Bistrian B, Collier S, Driscoll DF, Gura K, Houston DR, Miles J, Mirtallo J, Mogensen KM, Seidner D. Parenteral nutrition intravenous fat emulsions product shortage considerations. Nutr Clin Pract. 2013 Aug; 28(4):528-9. PMID: 23917440.
      Citations:    Fields:    Translation:Humans
    12. Driscoll DF, Newton DW, Bistrian BR. Potential hazards of precipitation associated with calcium chloride in parenteral nutrition admixtures: response to Migaki et al. JPEN J Parenter Enteral Nutr. 2012 Sep; 36(5):497-8; author reply 498-500. PMID: 22835937.
      Citations: 3     Fields:    Translation:Humans
    13. Martin CR, Dasilva DA, Cluette-Brown JE, Dimonda C, Hamill A, Bhutta AQ, Coronel E, Wilschanski M, Stephens AJ, Driscoll DF, Bistrian BR, Ware JH, Zaman MM, Freedman SD. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J Pediatr. 2011 Nov; 159(5):743-749.e1-2. PMID: 21658712.
      Citations: 81     Fields:    Translation:Humans
    14. Driscoll DF, Silvestri AP, Bistrian BR. Stability of MCT/LCT-based total nutrient admixtures for neonatal use over 30 hours at room temperature: applying pharmacopeial standards. JPEN J Parenter Enteral Nutr. 2010 May-Jun; 34(3):305-12. PMID: 20467013.
      Citations: 3     Fields:    Translation:Humans
    15. Joy J, Silvestri AP, Franke R, Bistrian BR, Nehne J, Newton DW, Driscoll DF. Calcium and phosphate compatibility in low-osmolarity parenteral nutrition admixtures intended for peripheral vein administration. JPEN J Parenter Enteral Nutr. 2010 Jan-Feb; 34(1):46-54. PMID: 19846668.
      Citations: 2     Fields:    Translation:HumansCells
    16. Driscoll DF, Ling PR, Bistrian BR. Pharmacopeial compliance of fish oil-containing parenteral lipid emulsion mixtures: Globule size distribution (GSD) and fatty acid analyses. Int J Pharm. 2009 Sep 08; 379(1):125-30. PMID: 19559776.
      Citations: 3     Fields:    
    17. Driscoll DF, Thoma A, Franke R, Klütsch K, Nehne J, Bistrian BR. Lipid globule size in total nutrient admixtures prepared in three-chamber plastic bags. Am J Health Syst Pharm. 2009 Apr 01; 66(7):649-56. PMID: 19299372.
      Citations: 4     Fields:    Translation:Humans
    18. Singh H, Dumas GJ, Silvestri AP, Young S, Martin CR, Bistrian BR, Driscoll DF. Physical compatibility of neonatal total parenteral nutrition admixtures containing organic calcium and inorganic phosphate salts in a simulated infusion at 37 degrees C. Pediatr Crit Care Med. 2009 Mar; 10(2):213-6. PMID: 19188866.
      Citations: 4     Fields:    Translation:HumansCells
    19. Driscoll DF. Pure long-chain triglyceride emulsion exhibited physicochemical stability in parenteral all-in-one admixtures for neonates. JPEN J Parenter Enteral Nutr. 2009 Jul-Aug; 33(4):451-2. PMID: 19234084.
      Citations:    Fields:    Translation:Humans
    20. Driscoll DF, Ling PR, Andersson C, Bistrian BR. Hepatic indicators of oxidative stress and tissue damage accompanied by systemic inflammation in rats following a 24-hour infusion of an unstable lipid emulsion admixture. JPEN J Parenter Enteral Nutr. 2009 May-Jun; 33(3):327-35. PMID: 19221047.
      Citations: 4     Fields:    Translation:Animals
    21. Driscoll DF. The pharmacopeial evolution of intralipid injectable emulsion in plastic containers: from a coarse to a fine dispersion. Int J Pharm. 2009 Feb 23; 368(1-2):193-8. PMID: 18996455.
      Citations: 3     Fields:    Translation:Humans
    22. Driscoll DF, Ling PR, Silvestri AP, Bistrian BR. Fine vs. coarse complete all-in-one admixture infusions over 96 hours in rats: fat globule size and hepatic function. Clin Nutr. 2008 Dec; 27(6):889-94. PMID: 18849096.
      Citations: 4     Fields:    Translation:Animals
    23. Newton DW, Driscoll DF. Chemistry and safety of phosphates injections. Am J Health Syst Pharm. 2008 Sep 15; 65(18):1761-6. PMID: 18769005.
      Citations: 2     Fields:    
    24. Driscoll DF, Bistrian BR, Demmelmair H, Koletzko B. Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology. Clin Nutr. 2008 Aug; 27(4):497-503. PMID: 18582994.
      Citations: 7     Fields:    Translation:HumansCells
    25. Newton DW, Driscoll DF. Calcium and phosphate compatibility: revisited again. Am J Health Syst Pharm. 2008 Jan 01; 65(1):73-80. PMID: 18159044.
      Citations: 11     Fields:    Translation:HumansCells
    26. Martin CR, Dumas GJ, Shoaie C, Zheng Z, Mackinnon B, Al-Aweel I, Bistrian BR, Pursley DM, Driscoll DF. Incidence of hypertriglyceridemia in critically ill neonates receiving lipid injectable emulsions in glass versus plastic containers: a retrospective analysis. J Pediatr. 2008 Feb; 152(2):232-6. PMID: 18206695.
      Citations: 3     Fields:    Translation:Humans
    27. Driscoll DF. Globule-size distribution in injectable 20% lipid emulsions: Compliance with USP requirements. Am J Health Syst Pharm. 2007 Oct 01; 64(19):2032-6. PMID: 17893413.
      Citations: 5     Fields:    Translation:Humans
    28. Driscoll DF, Ling PR, Bistrian BR. Physical stability of 20% lipid injectable emulsions via simulated syringe infusion: effects of glass vs plastic product packaging. JPEN J Parenter Enteral Nutr. 2007 Mar-Apr; 31(2):148-53. PMID: 17308256.
      Citations: 3     Fields:    Translation:Humans
    29. Driscoll DF, Silvestri AP, Bistrian BR, Mikrut BA. Stability of total nutrient admixtures with lipid injectable emulsions in glass versus plastic packaging. Am J Health Syst Pharm. 2007 Feb 15; 64(4):396-403. PMID: 17299179.
      Citations: 5     Fields:    Translation:Humans
    30. Driscoll DF, Parikh M, Silvestri AP, Klütsch K, Bistrian BR, Nehne J. Establishing a stability window for medium- and long-chain-triglyceride lipid-based total nutrient admixtures using USP standards. Am J Health Syst Pharm. 2006 Nov 01; 63(21):2135-43. PMID: 17057052.
      Citations:    Fields:    
    31. Driscoll DF. Lipid injectable emulsions: Pharmacopeial and safety issues. Pharm Res. 2006 Sep; 23(9):1959-69. PMID: 16951994.
      Citations: 40     Fields:    Translation:HumansAnimals
    32. Driscoll DF. Lipid injectable emulsions: 2006. Nutr Clin Pract. 2006 Aug; 21(4):381-6. PMID: 16870806.
      Citations: 5     Fields:    Translation:HumansAnimals
    33. Driscoll DF, Nehne J, Peterss H, Klutsch K, Bistrian BR, Niemann W. Physical assessments of lipid injectable emulsions via microscopy: a comparison to methods proposed in United States pharmacopeia chapter 729. Int J Pharm Compd. 2006 Jul-Aug; 10(4):309-15. PMID: 23974264.
      Citations: 6     Fields:    
    34. Driscoll DF, Ling PR, Bistrian BR. Pathological consequences to reticuloendothelial system organs following infusion of unstable all-in-one mixtures in rats. Clin Nutr. 2006 Oct; 25(5):842-50. PMID: 16682100.
      Citations: 6     Fields:    Translation:Animals
    35. Driscoll DF, Silvestri AP, Nehne J, Klütsch K, Bistrian BR, Niemann W. Physicochemical stability of highly concentrated total nutrient admixtures for fluid-restricted patients. Am J Health Syst Pharm. 2006 Jan 01; 63(1):79-85. PMID: 16373469.
      Citations: 2     Fields:    Translation:Humans
    36. Parikh MJ, Dumas G, Silvestri A, Bistrian BR, Driscoll DF. Physical compatibility of neonatal total parenteral nutrient admixtures containing organic calcium and inorganic phosphate salts. Am J Health Syst Pharm. 2005 Jun 01; 62(11):1177-83. PMID: 15914878.
      Citations: 10     Fields:    Translation:HumansCells
    37. Driscoll DF. Stability and compatibility assessment techniques for total parenteral nutrition admixtures: setting the bar according to pharmacopeial standards. Curr Opin Clin Nutr Metab Care. 2005 May; 8(3):297-303. PMID: 15809533.
      Citations: 8     Fields:    Translation:Humans
    38. Driscoll M, Driscoll DF. Calculating aluminum content in total parenteral nutrition admixtures. Am J Health Syst Pharm. 2005 Feb 01; 62(3):312-5. PMID: 15719591.
      Citations: 1     Fields:    Translation:Humans
    39. Driscoll DF, Ling PR, Quist WC, Bistrian BR. Pathological consequences from the infusion of unstable lipid emulsion admixtures in guinea pigs. Clin Nutr. 2005 Feb; 24(1):105-13. PMID: 15681108.
      Citations: 3     Fields:    Translation:Animals
    40. Driscoll DF, Dunbar JG, Marmarou A. Fat-globule size in a propofol emulsion containing sodium metabisulfite. Am J Health Syst Pharm. 2004 Jun 15; 61(12):1276-80. PMID: 15259759.
      Citations: 2     Fields:    
    41. Driscoll DF, Driscoll JJ. At the bedside. America (NY). 2004 Jun 7- Jun 14; 190(19):29. PMID: 15459986.
      Citations:    Fields:    
    42. Driscoll DF. Compounding TPN admixtures: then and now. JPEN J Parenter Enteral Nutr. 2003 Nov-Dec; 27(6):433-8; quiz 439. PMID: 14621126.
      Citations: 7     Fields:    Translation:Humans
    43. Driscoll DF. Sterility of fat emulsion in plastic syringes. Am J Health Syst Pharm. 2003 Jan 15; 60(2):197; author reply 198. PMID: 12561670.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    44. Sacks GS, Driscoll DF. Does lipid hang time make a difference? Time is of the essence. Nutr Clin Pract. 2002 Oct; 17(5):284-90. PMID: 16215002.
      Citations: 1     Fields:    
    45. Driscoll DF, Nehne J, Peterss H, Franke R, Bistrian BR, Niemann W. The influence of medium-chain triglycerides on the stability of all-in-one formulations. Int J Pharm. 2002 Jun 20; 240(1-2):1-10. PMID: 12062496.
      Citations: 9     Fields:    
    Driscoll's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (149)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _